Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas

NCT00001237 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

NIH

Sponsor class

Conditions

Burkitt Lymphoma
Lymphoma, Large-Cell, Diffuse
Lymphoma, Small Noncleaved-Cell

Interventions

DRUG: granulocyte-macrophage colony stimulating factor (GM-CSF)

Sponsor

National Cancer Institute (NCI)